Edition:
United States

Health News

Photo

Long-acting injection a shot in the arm for GSK's HIV business 4:31am EDT

LONDON A long-acting injection developed by GlaxoSmithKline and given once a month has proved as effective as standard daily pills for controlling the AIDS virus, lifting prospects for the British drugmaker's key HIV business.

More Headlines

Congo deploys experimental Ebola treatment as cases rise

GOMA, Democratic Republic of Congo/GENEVA Democratic Republic of Congo has started using the experimental mAb114 Ebola treatment to counter the latest flare-up of the virus, health officials said on Tuesday, the first time it has been deployed against an active outbreak.

Congo Aug 14 2018

Traumatic brain injury tied to increased risk of suicide

(Reuters Health) - People who have traumatic brain injuries may be nearly twice as likely to die by suicide as individuals who don't have a history of injuries like concussions and skull fractures, a large Danish study suggests.

Aug 14 2018

Men, like women, can have post-sex blues

(Reuters Health) - After sex, men can sometimes experience a myriad of confusing negative feelings, a phenomenon called post-coital dysphoria (PCD), which can interfere with relationships, researchers say.

Aug 14 2018

People taking HIV-prevention pill may get more primary care

(Reuters Health) - When people take daily pills to minimize their chances of getting HIV, they are also more likely to get routine care like flu shots and recommended screenings for common health problems, a U.S. study suggests.

Aug 14 2018